Sarissa Capital Management’s Quest Diagnostics DGX Stock Holding History

Sarissa Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-50,000	Closed	-$4.23M	–	12
2016 Q3	$4.23M	Sell	50,000 -109,000	-69%	-$9.15M	0.97%	11
2016 Q2	$12.9M	Sell	159,000 -416,000	-72%	-$31.7M	3.67%	8
2016 Q1	$41.1M	Hold	575,000	–	–	9.05%	5
2015 Q4	$40.9M	Hold	575,000	–	–	7.95%	5
2015 Q3	$35.3M	Hold	575,000	–	–	8.73%	4
2015 Q2	$41.7M	Sell	575,000 -200,000	-26%	-$14.8M	9.6%	3
2015 Q1	$59.6M	Hold	775,000	–	–	12.56%	3
2014 Q4	$52M	Hold	775,000	–	–	18.4%	2
2014 Q3	$47M	Hold	775,000	–	–	18.16%	2
2014 Q2	$45.5M	Hold	775,000	–	–	15.47%	3
2014 Q1	$44.9M	Buy	775,000 +75,000	+11%	+$4.02M	15.46%	2
2013 Q4	$37.5M	Buy	+700,000	New	+$41.5M	14.04%	2

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Sarissa Capital Management's DGX Position: Q4 2016 in Review

Sarissa Capital Management sold out of Quest Diagnostics (DGX) in Q4 2016, closing a stake of 50,000 shares — an estimated $4.23M sold.

Sarissa Capital Management first reported a position in DGX in Q4 2013 and held it in 12 quarters. The position peaked at $59.6M in Q1 2015. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.

Sarissa Capital Management reported no remaining Quest Diagnostics position as of Q4 2016 after selling out during the quarter.
Sarissa Capital Management sold 50,000 Quest Diagnostics shares in Q4 2016, an estimated $4.23M.
Sarissa Capital Management first reported a position in Quest Diagnostics in Q4 2013 and held it in 12 quarters.
Sarissa Capital Management's Quest Diagnostics position peaked at $59.6M in Q1 2015.
598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.

Based on Sarissa Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.